3/A//SEC Filing
SR One Capital Fund I Aggregator LP 3/A
Accession 0001209191-21-023612
CIK 0001807120other
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 5:44 PM ET
Size
10.2 KB
Accession
0001209191-21-023612
Insider Transaction Report
Form 3/AAmended
SR One Capital Fund I Aggregator LP
10% Owner
Holdings
Series A Preferred Stock
→ Common Stock (4,439,839 underlying)Series B Preferred Stock
→ Common Stock (936,637 underlying)
SR ONE CAPITAL PARTNERS I, LP
10% Owner
Holdings
Series B Preferred Stock
→ Common Stock (936,637 underlying)Series A Preferred Stock
→ Common Stock (4,439,839 underlying)
SR ONE CAPITAL MANAGEMENT, LLC
10% Owner
Holdings
Series B Preferred Stock
→ Common Stock (936,637 underlying)Series A Preferred Stock
→ Common Stock (4,439,839 underlying)
Footnotes (3)
- [F1]This amendment is being filed to add SR One Capital Partners I, LP and SR One Capital Management, LLC as joint filers to the Form 3 filed by SR One Capital Fund I Aggregator, LP on March 25, 2021.
- [F2]All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock at a rate of 1 share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect, at the Reporting Person's election and automatically upon the closing of the initial public offering of Design Therapeutics, Inc. (the "Issuer"). The Preferred Stock has no expiration date.
- [F3]The reported securities are held directly by SR One Capital Fund I Aggregator, LP. SR One Capital Partners I, LP is the general partner of SR One Capital Fund I Aggregator, LP, and SR One Capital Management, LLC is the general partner of SR One Capital Partners I, LP. Simeon George, M.D. is the managing member of SR One Capital Management, LLC. Each of SR One Capital Partners I, LP, SR One Capital Management, LLC and Mr. George may each be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
Documents
Issuer
Design Therapeutics, Inc.
CIK 0001807120
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001848319
Filing Metadata
- Form type
- 3/A
- Filed
- Mar 29, 8:00 PM ET
- Accepted
- Mar 30, 5:44 PM ET
- Size
- 10.2 KB